Nizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.
Published January 29, 2020 · Recall initiated: January 7, 2020
Summary
FDA records drug Class II recall D-0791-2020, published January 29, 2020 and initiated January 7, 2020. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 31,736 bottles of 60 capsules; Lot: Lot Number: 3086746, exp. date May 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Product was distributed to wholesalers, distributors , retail pharmacies, charitable organizations and mail order pharmacies throughout the United States and the product may have been further distributed.
- Lot
- Lot Number: 3086746, exp. date May 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACandesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDCOctober 28, 2020
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDASotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WVMarch 25, 2020
- FDANizatidine Capsules, USP 300 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5300-93.January 29, 2020
- FDALIFEPAK 15 MONITOR/DEFIBRILLATOR that was either manufactured with or received an upgrade kit that containedJanuary 22, 2020
- FDADawson-Mueller Drainage Catheter, Multipurpose Drainage Catheter, RPN UL T6.3-35-15-P-5S-CLDM-HC, UL T6.January 22, 2020
Questions about this recall
Was Nizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91. recalled?
Yes. FDA published recall D-0791-2020 on January 29, 2020. Reported hazard: CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.
What should I do if I have this product?
Voluntary: Firm initiated · Letter